Men Living With HIV and Experiencing Sexual Dysfunction: An Analysis of Treatment Options

Journal of the Association of Nurses in AIDS Care

Volumn 24, Issue SUPPL. 1, 2013, Pages

  Roberson, Donna W ^a   Kosko, Debra A ^a  

^a EAST CAROLINA UNIVERSITY   (United States)

Author keywords

Erectile dysfunction (ED); HIV infection; Hypogonadism; Phosphodiesterase 5 inhibitors (PDE5); Testosterone replacement

Indexed keywords

ARTICLE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; PATHOPHYSIOLOGY; SEXUALITY;

FEMALE; HIV INFECTIONS; HUMANS; MALE; SEXUALITY;

EID: 84871771449     PISSN: 10553290     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jana.2012.08.010     Document Type: Article

References (34)

1. Asboe D., Catalan J., Mandalia S., Dedes N., Florence E., Schrooten W., Colebunders R. Sexual dysfunction in HIV-positive men is multi-factorial: A study of prevalence and associated factors. AIDS Care 2007, 19(8):955-965. 10.1080/09540120701209847.
2. Basaria S., Coviello A., Travison T., Storer T., Farwell W., Jette A., Bhasin S. Adverse events associated with testosterone administration. New England Journal of Medicine 2010, 363:109-122.
3. Bhasin S., Cunningham G., Hayes F., Matsumoto A., Snyder P., Swerdloff R., Montori V.M. Testosterone therapy in men with androgen deficiency syndromes: An endocrine society clinical practice guideline. Journal of Clinical Endocrinology and Metabolism 2010, 95:2536-2559. 10.1210/jc.2009-2354.
4. Brewer D., Golden M., Handsfield H. Unsafe sexual behavior and correlates of risk in a probability sample of men who have sex with men in the era of highly active antiretroviral therapy. Sexually Transmitted Diseases 2006, 33(4):250-255. 10.1097/01.olq.0000194595.90487.
5. Carey J., Mejia R., Bingham T., Ciesielski C., Gelaude D., Herbst J., Jenkins R.A. Drug use, high-risk sex behaviors, and increased risk for recent HIV infection among men who have sex with men in Chicago and Los Angeles. AIDS Behavior 2009, 13:1084-1096. 10.1007/s10461-008-9403-3.
6. Collazos J. Sexual dysfunction in the highly active antiretroviral era. AIDS Review 2007, 9:237-245.
7. Collazos J., Martinez E., Mayo J., Ibarra S. Sexual dysfunction in HIV-infected patients treated with highly active antiretroviral therapy. Journal of Acquired Immune Deficiency Syndrome 2002, 31:322-326.
8. Cook R., McGinnis K., Samet J., Fielin D., Rodriquez-Barradas M., Kraemer K., Mattacks K. Erectile dysfunction drug receipt, risky sexual behavior and sexually transmitted diseases in HIV-infected and HIV-uninfected men. Journal of General Internal Medicine 2009, 25(2):115-121. 10.1007/s11606-009-1164-9.
9. Crum N., Furtek K., Olson P., Amling C., Wallace M. A review of hypogonadism and erectile dysfunction among HIV-infected men during the pre- and post-HAART eras: Diagnosis, pathogenesis and management. AIDS Patient Care 2005, 19(10):655-671. 10.1089/apc.2005.19.655.
10. Crum-Cianflone N., Bavaro M., Hale B., Amling C., Truett A., Brandt C., Wallace M.R. Erectile dysfunction and hypogonadism among men with HIV. AIDS Patient Care and STDs 2007, 21(1):9-19. 10.1089/apc.2006.0071.
11. de Andrade E., deMesquita A., de Almeida Claro J., de Andrade P., Ortiz V., Paranhos M., Srougi M. Study of the efficacy of Korean Red Ginseng in the treatment of erectile dysfunction. Asian Journal of Andrology 2007, 9(2):241-244. 10.1111/j.1745-7262.2007.00210.x.
12. Ende A., Re V., DiNubile M., Mounzer K. Erectile dysfunction in an urban HIV-positive population. AIDS Patient Care 2006, 20(2):75-78. 10.1089/apc.2006.20.75.
13. Ernst E., Posadzki P., Lee M. Complementary and alternative medicine (CAM) for sexual dysfunction and erectile dysfunction in older men and women: An overview of systematic reviews. Maturitas 2011, 70:37-41. 10.1016/j.maturitas.2011.06.011.
14. Holmer A. Direct-to-consumer advertising: Strengthening our health care system. New England Journal of Medicine 2002, 346(7):526-528.
15. Jang D., Lee M., Shin B., Lee Y., Ernst E. Red ginseng for treating erectile dysfunction: A systematic review. British Journal of Clinical Pharmacology 2008, 66(4):444-450. 10.1111/j.1365-2125.2008.03236x.
16. Kalyani R., Gavini S., Dobs A. Male hypogonadism in systemic disease. Endocrinology and Metabolism Clinics of North America 2007, 36:333-348. 10.1016/j.ecl.2007.03.014.
17. Koole O., Noestlinger C., Colebunders R. Quality of life in HIV clinical trials: Why sexual health must not be ignored. PLOS Clinical Trial 2007, 2(3):e8. 10.1371/journal.pctr.0020008.
18. Lazarou S., Morgentaler A. Hypogonadism in the man with erectile dysfunction: What to look for and when to treat. Current Urology Reports 2005, 6:476-481. 10.1007/s11934-005-0044-z.
19. Lebret T., Herve J., Gorny P., Worcel M., Botto H. Efficacy and safety of a novel combination of L-arginine glutamate and yohimbine hydrochloride: A new oral therapy for erectile dysfunction. European Urology 2002, 41:608-613. 10.1016/S0302-2838(02)00175-6.
20. MacKay D. Nutrients and botanicals for erectile dysfunction: Examining the evidence. Alternative Medicine Review 2004, 9(1):4-16.
21. Mayo Medical Laboratories. (2012). Testosterone, total, bioavailable, and free serum. Retrieved from http://www.mayomedicallaboratories.com/test-catalog/Clinical+and+Interpretive/83686.
22. MedlinePlus. (2011). Yohimbe. Retrieved from http://www.nlm.nih.gov/medlineplus/druginfo/natural/759.html.
23. Mikhail N. Does testosterone have a role in erectile function?. American Journal of Medicine 2006, 119:373-382. 10.1016/j.amjmed.2005.07.042.
24. Park J., Shin D., Ahn T. Complementary and alternative medicine in men's health. Journal of Men's Health 2008, 5(4):305-313. 10.1016/j.jomh.2008.08.004.
25. Patel J., Buddha B., Dey S., Pal D., Mitra A. In vitro interaction of the HIV protease inhibitor ritonavir with herbal constituents: Changes in P-gp and CYP3A4 activity. American Journal of Therapeutics 2004, 11:262-277.
26. Prestage G., Jin F., Kippax S., Zablotska I., Imrie J., Grulich A. Use of illicit drugs and erectile dysfunction medications and subsequent HIV infection among gay men in Sydney, Australia. Journal of Sexual Medicine 2009, 6(8):2311-2320. 10.1111/j.1743-6109.2009.01323.x.
27. Rabkin J., Wagner G., Rabkin R. A double-blind, placebo-controlled trial of testosterone therapy for HIV-positive men with hypogonadal symptoms. Archives of General Psychiatry 2000, 57:141-147. 10.1001/archpsyc.57.2.141.
28. Rosen R., Cappelleri J., Smith M., Lipsky J., Pena B. Development and evaluation of an abridged, 5-item version of the international index of erectile function (IIEF-5) as a diagnostic tool for erectile dysfunction. International Journal of Impotence Research 1999, 11:319-326.
29. Scanavino M. Sexual dysfunctions of HIV-positive men: Associated factors, pathophysiology issues, and clinical management. Advances in Urology 2011, 2011:854792. 10.1155/2011/854792.
30. Shin, B., Lee, M., Yang, E., Lim, H., & Ernst, E. (2010). Maca (L. meyenii) for improving sexual function: A systematic review. BMC Complementary and Alternative Medicine, 10(44). Retrieved from doi:10.1186/1472-6882-10-44. http://www.biomedcentral.com/1472-6882/10/44.
31. Shindel A., Horberg M., Smith J., Breyer B. Sexual dysfunction, HIV, and AIDS in men who have sex with men. AIDS Patient Care and STDs 2011, 25(6):341-349. 10.1089/apc.2011.0059.
32. Trotta M., Ammassari A., Murri R., Marconi P., Zaccarelli M., Cozzi-Lepri A., Antinori A. Self-reported sexual dysfunction is frequent among HIV-infected persons and is associated with suboptimal adherence to antiretrovirals. AIDS Patient Care and STDs 2008, 22(4):291-299. 10.1089/apc.2007.0061.
33. United States Department of Veterans Affairs. (2011). Androgen deficiency: Primary care of veterans with HIV. Retrieved from http://www.hiv.va.gov/provider/manual-primary-care/androgen-deficiency.asp.
34. Yiu P., Nguyen N., Holodniy M. Clinically significant drug interactions in younger and older human immunodeficiency virus: Positive patients receiving antiretroviral therapy. Pharmacotherapy 2011, 31(5):480-489. 10.1592/phco.31.5.480.